VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Aromatase inhibitors in metastatic breast cancer.
Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer.
Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer. Cancer Discov. 2020 02; 10(2):198-213.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms
Breast Neoplasms, Male
Cell Line, Tumor
DNA Mutational Analysis
Drug Resistance, Neoplasm
Drug Synergism
Estrogen Receptor Antagonists
Female
Humans
Male
Middle Aged
Mutation
Prospective Studies
Protein Kinase Inhibitors
Quinolines
Receptor, ErbB-2
Receptors, Estrogen
Signal Transduction
Treatment Outcome